IFNA2 and COVID-19: As far as transcriptomic signatures are concerned, in severely ill COVID-19 patients, TNF-α signaling pathways are enriched, resulting in increased expression of multiple ISGs, revealing more robust activation of innate immunity in this group of patients [84], whereas in mild patients, pathways linked to IFN-α/γ responses are significantly enriched.